Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06876974

Assessment of Prognosis and Myocardial Reperfusion in Patients with ST-segment-elevation Myocardial Infarction (STEMI) According to Coronary Atherosclerotic Burden.

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
2,200 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In the current literature, it has been widely demonstrated that the extend of coronary atherosclerotic burden is associated with adverse long-term outcomes. Little is known about the impact of atheroma burden and either myocardial reperfusion and short-term outcomes after ST-segment elevation myocardial infarction (STEMI). Several angiographic scores have been used to measure the extend and severity of coronary atheroma. The SYNTAX score and the Gensini score have been shown to be independent predictors of cardiovascular events and mortality in stable coronary artery disease as well as in myocardial infarction. This research therefore aims to assess the impact of overall coronary atherosclerotic burden, measured by two angiographic scores (SYNTAX score and Gensini score), both before and after primary percutaneous angioplasty, in patients with STEMI according to different clinical subgroups.

Conditions

Timeline

Start date
2025-03-01
Primary completion
2025-03-01
Completion
2025-03-01
First posted
2025-03-14
Last updated
2025-03-14

Source: ClinicalTrials.gov record NCT06876974. Inclusion in this directory is not an endorsement.

Assessment of Prognosis and Myocardial Reperfusion in Patients with ST-segment-elevation Myocardial Infarction (STEMI) A (NCT06876974) · Clinical Trials Directory